RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Human soluble FcRn and Beta2-microglobulin expressing vector
A vector to be used for transfection and purification of human soluble FcRn receptor More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Follicular Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 213 pages - $500
Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 672 pages - $500
CNS Lymphoma - Pipeline Review, Q1 2011
Jan 2011 - 18 pages - $500
Burkitt Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 26 pages - $500
Mantle Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 268 pages - $500
HIV-Related Lymphoma - Pipeline Review, Q1 2011
Jan 2011 - 18 pages - $500
Diffuse Large B-Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 351 pages - $500
Cutaneous T-Cell Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 47 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Research tools del
Therapeutic target
Oncology del
Lymphoma del
Development phase
Registered del

Browse By

Industry sector
Antibodies
Antigens
Biomarkers
Cell lines
Mouse models
Reagents
Vectors
Therapeutic target
Hodgkin's lymphoma
Lymphoma, AIDS-related
Neoplastic disease
Non-Hodgkins lymphoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us